[HTML][HTML] Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant

…, MRA Sater, MH Huntley, S Turbett… - … England Journal of …, 2019 - Mass Medical Soc
Fecal microbiota transplantation (FMT) is an emerging therapy for recurrent or refractory
Clostridioides difficile infection and is being actively investigated for other conditions. We …

Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients

…, TM Caradonna, JA Branda, SE Turbett… - Science …, 2020 - science.org
We measured plasma and/or serum antibody responses to the receptor-binding domain (RBD)
of the spike (S) protein of SARS-CoV-2 in 343 North American patients infected with …

Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events

…, M Burns, CM Brown, J Luban, ET Ryan, SE Turbett… - Science, 2021 - science.org
INTRODUCTION We used genomic epidemiology to investigate the introduction and spread
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the Boston area …

[PDF][PDF] Comparative transmissibility of SARS-CoV-2 variants delta and alpha in New England, USA

…, R Uddin, N Matluk, N Renzette, SE Turbett… - Cell Reports …, 2022 - cell.com
The SARS-CoV-2 Delta variant rose to dominance in mid-2021, likely propelled by an
estimated 40%–80% increased transmissibility over Alpha. To investigate if this ostensible …

Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain

…, V Brusic, NV Tolan, G Zhou, M Desjardins, SE Turbett… - Science, 2021 - science.org
Many studies have examined the impact of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) variants on neutralizing antibody activity after they have become dominant …

Characterization of virologic rebound following nirmatrelvir-ritonavir treatment for coronavirus disease 2019 (COVID-19)

…, TD Vyas, JM Vyas, SE Turbett… - Clinical Infectious …, 2023 - academic.oup.com
We enrolled 7 individuals with recurrent symptoms or antigen test conversion following
nirmatrelvir-ritonavir treatment. High viral loads (median 6.1 log 10 copies/mL) were detected …

Viral lineages in the 2022 RSV surge in the United States

…, J Luban, A Ozonoff, DJ Park, SE Turbett… - … England Journal of …, 2023 - Mass Medical Soc
RSV Surge and Viral Lineages, 2022 A surge in RSV infections occurred across the United
States in late 2022. In this report, multiple RSV lineages are identified as contributing to the …

Evaluation of three commercial SARS-CoV-2 serologic assays and their performance in two-test algorithms

SE Turbett, M Anahtar, AS Dighe… - Journal of clinical …, 2020 - Am Soc Microbiol
Sensitive and specific severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
serologic assays are needed to inform diagnostic, therapeutic, and public health decision-making…

Distinguishing Severe Acute Respiratory Syndrome Coronavirus 2 Persistence and Reinfection: A Retrospective Cohort Study

SE Turbett, CH Tomkins-Tinch… - Clinical Infectious …, 2023 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection is
poorly understood, partly because few studies have systematically applied genomic analysis …

Donor-Derived Transmission of Candida auris During Lung Transplantation

MM Azar, SE Turbett, JA Fishman… - Clinical Infectious …, 2017 - academic.oup.com
Candida auris is an emerging, often multidrug-resistant pathogen with important public health
implications. Infections are associated with high mortality, and prevention of transmission …